"10.1371_journal.pone.0147917","plos one","2016-01-29T00:00:00Z","Lynne Hampson; Innocent O Maranga; Millicent S Masinde; Anthony W Oliver; Gavin Batman; Xiaotong He; Minaxi Desai; Parmenas M Okemwa; Helen Stringfellow; Pierre Martin-Hirsch; Alex M Mwaniki; Peter Gichangi; Ian N Hampson","University of Manchester Viral Oncology Laboratories, Institute of Cancer Sciences, Research Floor 5, St Marys Hospital, Oxford Road, Manchester M13 9WL, United Kingdom; Kenyatta National Hospital, Department of Reproductive Health, PO Box 20723–00202, Nairobi, Kenya; University of Nairobi, College of Health Sciences, Departments of Gynaecology and Pathology, PO Box 19676–00202, Nairobi, Kenya; Cytology Laboratories, PO Box 208, Clinical Sciences Building 2, Central Manchester University Hospital NHS Trust, Oxford Rd, Manchester M13 9WW, United Kingdom; Department of Pathology, Royal Preston Hospital, Sharoe Green Lane, Fulwood, Preston, PR2 9HT, United Kingdom; Department of Obstetrics & Gynaecology, Royal Preston Hospital, Sharoe Green Lane, Fulwood, Preston, PR2 9HT, United Kingdom","Conceived and designed the experiments: INH LH IOM MD PG. Performed the experiments: IOM LH MSM MD PMO HS GB AWO XH. Analyzed the data: INH LH IOM MD PMH AMM. Wrote the paper: INH LH IOM PMH MD.","The authors have the following interests: Hologic Inc. loaned diagnostic equipment, including set-up and maintenance costs, for this study. The University of Manchester has filed a patent on the use of Lopimune to treat HPV related early stage cervical neoplasia. Patent Application No PCT/GB2014/053169 Claiming priority from GB 1318742.2 and GB1409362.9 Treatment of Cancer and Benign Proliferative Disorders where INH and LH are named inventors. There are no further patents, products in development or marketed products to declare. This does not alter authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2016","01","Lynne Hampson","LH",13,TRUE,5,9,6,5,TRUE,TRUE,FALSE,0,NA,FALSE
